SVA
Sinovac Biotech LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$642.44M
P/E Ratio
6.66
EPS
$0.97
Beta
0.06
52W High
$6.47
52W Low
$6.47
50-Day MA
$6.47
200-Day MA
$6.47
Dividend Yield
850.00%
Profit Margin
21.60%
Forward P/E
—
PEG Ratio
0.00
About Sinovac Biotech Ltd
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacture and marketing of vaccines against human infectious diseases in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Fundamentals
| Revenue (TTM) | $510.62M |
| Gross Profit (TTM) | $443.44M |
| EBITDA | $219.50M |
| Operating Margin | 42.30% |
| Return on Equity | 25.20% |
| Return on Assets | 11.50% |
| Revenue/Share (TTM) | $5.16 |
| Book Value | $7.52 |
| Price-to-Book | 1.82 |
| Price-to-Sales (TTM) | 1.83 |
| EV/Revenue | 0.0309 |
| EV/EBITDA | 0.04 |
| Quarterly Earnings Growth (YoY) | 354.80% |
| Quarterly Revenue Growth (YoY) | 303.70% |
| Shares Outstanding | $99.30M |
| Float | $59.51M |
| % Insiders | 51.42% |
| % Institutions | 32.02% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($3.52 target)
Data last updated: 4/9/2026